1. Home
  2. TARS vs NATL Comparison

TARS vs NATL Comparison

Compare TARS & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$64.46

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$42.26

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
NATL
Founded
2016
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
TARS
NATL
Price
$64.46
$42.26
Analyst Decision
Buy
Hold
Analyst Count
6
4
Target Price
$89.00
$45.60
AVG Volume (30 Days)
526.9K
1.4M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
48.21
73.98
EPS
N/A
2.14
Revenue
$451,360,000.00
$4,354,000,000.00
Revenue This Year
$55.67
$6.13
Revenue Next Year
$30.64
$4.24
P/E Ratio
N/A
$20.02
Revenue Growth
146.71
0.86
52 Week Low
$38.51
$22.30
52 Week High
$85.25
$48.50

Technical Indicators

Market Signals
Indicator
TARS
NATL
Relative Strength Index (RSI) 37.12 45.30
Support Level $61.11 $37.97
Resistance Level $67.70 $43.43
Average True Range (ATR) 2.32 1.10
MACD -0.89 -0.52
Stochastic Oscillator 3.08 3.79

Price Performance

Historical Comparison
TARS
NATL

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

Share on Social Networks: